Cencora earnings were $1.6B for the trailing 12 months ending Dec 31, 2025, with 17.9% growth year over year. The latest COR earnings report on Dec 31, 2025 announced Q4 2025 earnings of $559.6M, down 264.7% from last quarter. For the last reported fiscal year 2025 ending Sep 30, 2025, COR reported annual earnings of $1.6B, with 3% growth.
COR past earnings growth
How has COR's earnings growth performed historically?
On COR's earnings call on Invalid Date, Cencora (NYSE: COR) reported Q4 2025 earnings per share (EPS) of $2.88, up 14.29% year over year. Total COR earnings for the quarter were $559.65 million. In the same quarter last year, Cencora's earnings per share (EPS) was $2.52.
As of the last Cencora earnings report, Cencora is currently profitable. Cencora's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $1.63 billion, a 16.4% increase year over year.
What was COR's earnings growth in the past year?
As of Cencora's earnings date in Invalid Date, Cencora's earnings has grown 17.86% year over year. This is 21.76 percentage points lower than the US Medical Distribution industry earnings growth rate of 39.62%. COR earnings in the past year totalled $1.63 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.